Clinical Trial Update: Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating a combination of high and low-dose radiotherapy with immunotherapy and a tyrosine kinase inhibitor in advanced, refractory co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Refractory Colorectal Cancer, Radiotherapy-Induced Immune Priming | Phase 2 | Status: NOT_YET_RECRUITING